Adventitious agents in viral vaccines: lessons learned from 4 case studies

Area of Science:

• Vaccinology and Virology
• Regulatory Science
• Biological Product Manufacturing

Background:

• Historical instances of adventitious agents detected in manufactured biological products, particularly vaccines, necessitate ongoing evaluation of regulatory strategies.
• Understanding past contamination events is crucial for enhancing the safety and reliability of viral vaccines.

Purpose of the Study:

• To analyze historical cases of adventitious agents found in viral vaccines to inform future regulatory preparedness.
• To identify key scientific principles for risk evaluation when adventitious agents are detected in marketed vaccines.

Main Methods:

• Case study analysis of four specific instances of adventitious agents or related signals in viral vaccines.
• Review of lessons learned from each historical event.
• Identification of scientific principles based on collective experiences, incorporating WHO recommendations.

Main Results:

• Detailed examination of four cases: SV40 in polio vaccines, bacteriophage in measles and polio vaccines, reverse transcriptase in measles and mumps vaccines, and porcine circovirus in rotavirus vaccines.
• Extraction of actionable lessons from each contamination event.
• Formulation of scientific principles for regulatory risk assessment of adventitious agents in vaccines.

Conclusions:

• Past occurrences of adventitious agents in vaccines provide valuable insights for strengthening regulatory oversight.
• Established scientific principles, informed by historical events and WHO guidance, are essential for managing risks associated with adventitious agents in vaccines.
• Proactive regulatory preparedness is key to ensuring vaccine safety and public health.